New Feature: See Wall Street analyst ratings directly on Finviz charts for deeper context into price action.

Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ

By Shaun Pruitt | April 16, 2025, 6:35 PM

Albertsons Companies Inc

Johnson & Johnson

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Johnson & Johnson (JNJ): Free Stock Analysis Report

Albertsons Companies, Inc. (ACI): Free Stock Analysis Report

The Kroger Co. (KR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Albertsons Companies Inc

Johnson & Johnson

Latest News

3 hours	Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure JNJ Zacks
4 hours	What Does the Street Think About Albertsons Companies (ACI)? ACI Insider Monkey
4 hours	Is The Kroger Co. (KR) One of the Best Natural and Organic Food Stocks to Buy Now? KR Insider Monkey
4 hours	Walmart Q4 Earnings Call Highlights KR MarketBeat
5 hours	Walmart (WMT) Q4 Earnings and Revenues Surpass Estimates KR Zacks
6 hours	J&J to build $1bn US CGT manufacturing site in Pennsylvania JNJ Pharmaceutical Technology
Feb-18	Kroger Celebrates Experience Makers in Honor of Supermarket Employee Day on Sunday, Feb. 22 KR PR Newswire
Feb-18	Halozyme's Q4 Earnings Miss, Higher Royalties Drive Y/Y Revenues JNJ Zacks
Feb-18	Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory JNJ The Wall Street Journal
Feb-18	Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania JNJ Business Wire
Feb-18	FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer JNJ Benzinga
Feb-18	Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy? JNJ 24/7 Wall St.
Feb-18	Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It JNJ Zacks
Feb-18	RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer JNJ PR Newswire
Feb-18	XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500 JNJ 24/7 Wall St.

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.